ArticleFrontiers in surgery2025
Construction and validation of a predictive model for postoperative stent occlusion in patients undergoing iliac vein stenting based on an explainable machine learning model.
Article in Frontiers in surgery, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objective: This study aims to develop an interpretable machine learning model for predicting post-operative iliac venous stent occlusion risk. Methods: Employing a retrospective cohort design, data from 826 patients across seven hospitals (January 2017-June 2024) were incorporated with stratified sampling into training ( Results: In independent testing-set validation, the AutoML model demonstrated superior robustness: ROC-AUC reached 0.9251 and PR-AUC 0.8712. Decision curve analysis confirmed significantly higher clinical net benefit across a wide threshold probability range (1%-87%) compared to conventional approaches, indicating exceptional generalizability. Calibration curves revealed the lowest Brier score (0.123) in the test set, further validating predictive accuracy. Outperforming comparative models [e.g., XGBoost [ROC-AUC 0.8203] and LightGBM [PR-AUC 0.7806]], AutoML dominated across all metrics including accuracy (0.7417) and F1-score (0.7559). Concurrently, SHAP analysis quantified critical feature contributions: Pathogenic triad (DVT + Cockett + PE); Hemodynamic thresholds (common femoral and external iliac vein recanalization rates both <70%); Stent geometric parameters (diameter >14 mm/inferior vena cava segment length >20 mm); With CRP > 10 mg/L and D-dimer > 1.5 mg/L coexistence elevating occlusion risk. Conclusion: The occlusion prediction system integrating AutoML with explainable AI successfully quantifies multi-level interactions, surpassing traditional predictive dimensions to provide evidence-based support for personalized anticoagulation and stent optimization.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.